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Abstract
Introduction:  Self-expanding  metal  stents  (SEMS)  as  a  bridge  to  surgery  have  been  used  as
an alternative  for  acute  malignant  left-sided  colonic  obstruction.  However,  the  beneﬁts  are
uncertain.  The  European  Society  of  Gastrointestinal  Endoscopy  no  longer  recommends  their
use in  patients  with  low  surgical  risk  because  of  the  risk  of  tumor  recurrence.
Methods:  Patients  admitted  for  acute  malignant  left-sided  colonic  obstruction  who  underwent
SEMS as  a  bridge  to  elective  surgery  or  urgent  surgery  were  retrospectively  evaluated.  Post-
operative morbidity/mortality,  stent  complications  and  survival  were  recorded.  Our  aim  was
to compare  the  outcome  between  preoperative  SEMS  and  direct  emergent  surgery  in  acute
left-sided  malignant  colonic  obstruction.
Results:  42  patients  were  included  (SEMS  group:  27  and  surgery  group:  15).  There  were  no
differences  between  groups  in  relation  to  age,  ASA  classiﬁcation  and  tumor  stage.  The  technical
success of  SEMS  was  88.9%  and  the  clinical  success  was  85.2%.  There  were  three  SEMS  related
perforations.  In  the  surgery  group,  the  stoma  rate  was  higher  (86.7%  vs  25.9%,  p  <  0.001)  and
there was  a  trend  for  a  lower  length  of  hospital  stay  (18.9  days  vs  26.3  days,  p  =  0.051).
SEMS verses  surgery  group:  There  were  no  differences  in  the  rate  of  temporary  stoma  (57.1%
vs 61.5%,  p  =  0.84),  deﬁnitive  stoma  (42.8%  vs  38.5%,  p  =  0.84),  success  of  primary  anastomosis
(86.7% vs  66.7%,  p  =  0.22)  and  Clavien--Dindo  classiﬁcation  (≥III:  36%  vs  58.2%  p  =  0.24).  Overall
survival  at  1/5  years  was  identical  in  the  two  groups  100%/56%  in  the  SEMS  group  vs  93%/43%
in the  surgery  group,  p  =  0.14),  as  well  as  tumor  recurrence  at  3/5  years  (24%/50%  vs  20%/36%
respectively,  p  =  0.68).∗ Corresponding author.
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Conclusions:  SEMS  are  associated  with  a  lower  overall  stoma  rate  and  a  higher  primary  anasto-
mosis rate.  However,  there  are  no  differences  in  complications,  overall  survival  and  recurrence
between  the  groups.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Published  by  Elsevier  España,  S.L.U.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
PALAVRAS-CHAVE
Neoplasias  do  Colon;
Obstruc¸ão  Intestinal;
Stents
Avaliac¸ão  das  Próteses  Metálicas  Auto-Expansíveis  Como  Ponte  Para  Cirurgia  nas
Neoplasias  Oclusivas  do  Cólon  Esquerdo:  Experiência  de  6  Anos
Resumo
Introduc¸ão: As  próteses  metálicas  auto-expansíveis  (PMAE)  como  ponte  para  cirurgia  são  uma
alternativa à  cirurgia  urgente  nas  neoplasias  estenosantes  do  colon  esquerdo.  No  entanto,  os
benefícios  são  controversos.  A  Sociedade  Europeia  de  Endoscopia  não  as  recomenda  como  ponte
para cirurgia  desde  2014,  em  doentes  de  baixo  risco  cirúrgico,  pelo  possível  aumento  de  recidiva
neoplásica.
Métodos: Avaliac¸ão  retrospetiva  dos  doentes  com  neoplasia  oclusiva  do  colon  esquerdo  can-
didatos a  tratamento  curativo,  que  colocaram  PMAE  como  ponte  para  cirurgia  ou  que  foram
submetidos  diretamente  a  tratamento  cirúrgico  urgente.  Avaliada  a  morbilidade  e  mortalidade
pós-operatória,  complicac¸ões  relacionadas  com  as  PMAE  e  sobrevivência.  O  nosso  objetivo  foi
comparar os  resultados  das  PMAE  como  ponte  para  cirurgia  com  o  tratamento  cirúrgico  urgente
nas neoplasias  oclusivas  do  colon  esquerdo.
Resultados:  Avaliados  42  doentes  (grupo  submetido  a  PMAE:  27;  grupo  submetido  a  cirurgia:15).
Não existem  diferenc¸as  entre  os  dois  grupos  no  que  diz  respeito  à  idade  classiﬁcac¸ão  ASA  e  o
estadio da  neoplasia.  O  sucesso  técnico  das  PMAE  foi  de  88,9%  e  o  sucesso  clínico  da  prótese
foi de  85,2%.  Ocorreram  3  perfurac¸ões  após  colocac¸ão  das  PMAE.
No grupo  submetido  a  cirurgia,  a  realizac¸ão  de  estoma  foi  superior  (86,7%  vs  25,9%),  p  <  0,001),
e veriﬁcou-se  um  menor  número  de  dias  de  internamento  hospitalar  total,  embora  sem  resultado
estatisticamente  signiﬁcativo  (18,9  vs  26,3  dias,  p  =  0,051).
PMAE  versus  cirurgia:  não  existem  diferenc¸as  no  que  diz  respeito  à  constituic¸ão  de  estomas
provisórios  (57,1%  vs  61,5%,  p  =  0,84),  estomas  deﬁnitivos  (42,8%  vs  38,5%,  p  =  0,84),  sucesso
de anastomose  primária  (86,7%  vs  66,7%,  p  =  0,22)  e  classiﬁcac¸ão  de  Clavien--Dindo  (≥III:36%  vs
58,2% p  =  0,24).  A  sobrevida  aos  1  e  5  anos  foi  semelhante  nos  dois  grupos  (PMAE  1-5  anos  vs
cirurgia 1-5  anos:  100%-56%  vs  93%-43%,  p  =  0,14),  bem  com  a  recidiva  aos  3  e  5  anos  (PMAE  3-5
anos vs  cirurgia  3-5  anos  24%-50%  vs  20%-36%,  p  =  0,68).
Conclusões:  A  realizac¸ão  de  estoma  foi  superior  nos  doentes  submetidos  a  tratamento  cirúr-
gico, no  entanto,  não  há  diferenc¸as  entre  os  dois  grupos  relativamente  às  complicac¸ões
pós-cirurgicas,  sucesso  de  anastomose  primária,  recidiva  e  mortalidade.
© 2016  Sociedade  Portuguesa  de  Gastrenterologia.  Publicado  por  Elsevier  España,  S.L.U.  Este  é
um artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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51. Introduction
Left-sided  colon  cancer  can  present  with  obstruction  in  8%
to  26%  of  cases.1,2 Large  bowel  obstruction  results  in  massive
colonic  distension,  bacterial  translocation,  electrolyte  and
ﬂuid  imbalance,  and  an  increased  risk  of  colonic  necrosis  and
perforation.3 In  this  situation,  urgent  colonic  decompression
is  necessary,  either  through  surgery  or  by  SEMS.
The  general  consensus  for  treatment  of  acute  right-sided
colonic  obstruction  is  resection  and  primary  anastomosis;
SEMS  placement  is  recommended  as  the  preferred  treatment
for  palliation  of  malignant  colonic  obstruction,  except  in
patients  treated  or  considered  for  treatment  with  antian-
giogenic  drugs.4 However,  for  patients  with  obstructive
p
A
aonpalliative  left-sided  colonic  cancer,  the  management
emains  controversial.  In  the  last  decade  many  studies
ave  been  published,  including  randomized  controlled  trials
RCTs)  and  systematic  reviews,  with  conﬂicting  results.
Some  RCT  showed  that  SEMS  as  a  bridge  to  surgery  with
urative  intent  may  be  safer,  with  a  trend  toward  lower
toma  rate,  post-surgical  complications  and  mortality  when
ompared  with  urgent  surgery.5,6 However,  another  study
ailed  to  demonstrate  that  urgent  preoperative  SEMS  could
igniﬁcantly  decrease  the  need  for  stoma  placement,  with
3.3%  of  SEMS  technical  failure.7 The  elevated  rate  of
erforations  lead  to  the  premature  closure  of  this  study.7
 meta-analysis  that  included  four  RCT  showed  that  SEMS
re  associated  with  a  high  incidence  of  clinical  and  silent
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erforations  and  that  technical  and  clinical  success  rates
or  stenting  were  lower  than  expected.3
A  recent  meta-analysis  with  seven  RCTs  demonstrated
hat  there  was  no  statistically  signiﬁcant  difference  in
he  postoperative  mortality  comparing  SEMS  as  bridge  to
urgery  (10.7%)  and  urgent  surgery  (12.4%).  The  SEMS  group
ad  lower  overall  morbidity  (33.1%  vs  53.9%,  p  =  0.03),  a
igher  successful  primary  anastomosis  rate  (67.2%  vs  55.1%,
 <  0.01)  and  lower  permanent  stoma  rate  (9%  vs  27.4%,
 <  0.01).8 This  study  concluded  that  SEMSs  are  a  safe  and
ffective  bridge  to  subsequent  surgery  in  patients  with
bstructing  left-sided  colon  cancer.
In  the  recent  guidelines  of  the  European  Society  of  Gas-
rointestinal  Endoscopy,  SEMS  placement  as  a  bridge  to
lective  surgery  is  no  longer  recommended  as  a  standard
reatment  for  symptomatic  left-sided  malignant  colonic
bstruction,  except  in  patients  with  ≥70  years  old  and
SA  ≥  III.4 Although  some  advantages  of  SEMSs  as  a  bridge
o  surgery  can  be  extracted  from  published  studies,  these
ecommendations  state  that  this  has  to  be  balanced
ith  the  oncological  outcomes  in  patients  with  a  curable
olonic  cancer.  Some  data  evaluated  this  issue,  showing  a
igher  oncologic  recurrence  in  the  SEMS  group,  which  was
ven  higher  in  patients  with  stent-related  perforation.6,9,10
ecause  there  is  no  reduction  in  postoperative  mortality
nd  stenting  seems  to  have  a  negative  impact  on  the  onco-
ogical  safety,  the  use  of  SEMSs  as  a  bridge  to  elective
urgery  is  no  longer  recommended  by  European  Society  of
astrointestinal  Endoscopy  (ESGE)  as  a  standard  treatment
or  potentially  curable  patients  with  left-sided  malignant
olonic  obstruction.4
Considering  these  new  recommendations,  our  aim  was  to
valuate  our  experience  with  SEMS  as  a  bridge  to  surgery
n  patients  with  obstructive  left-sided  colonic  cancer  com-
ared  to  urgent  surgery,  regarding  morbidity,  mortality  and
ncological  recurrence.
. Material and methods
.1.  Patient  selection  and  data  collection
atients  admitted  between  2008  and  2014  in  our  hospi-
al  for  acute  malignant  left-sided  colonic  obstruction  who
nderwent  urgent  endoscopic  stenting  as  a  bridge  to  elec-
ive  surgery  (SEMS-group)  or  urgent  surgery  (surgery-group)
ere  retrospectively  evaluated.  Left-sided  colonic  cancer
as  deﬁned  as  being  distal  to  and  including  the  splenic  ﬂex-
re  of  the  colon,  up  to  and  including  the  rectosigmoid  colon.
Diagnosis  of  acute  colonic  obstruction  was  made  clini-
ally,  based  on  symptoms  of  abdominal  pain  and  distention,
omiting,  and  inability  to  pass  stools,  and  conﬁrmed  radio-
ogically  on  plain  abdominal  ﬁlms  demonstrating  a  dilated
olon.  The  diagnosis  of  the  colonic  tumor  causing  the
bstruction  and  the  site  of  tumor  was  conﬁrmed  by  ﬂex-
ble  sigmoidoscopy  or  computer  tomography  scan  of  the
bdomen  and  pelvis.
Patients  with  rectal  cancer,  with  obstruction  due  to  non-
olonic  malignancy,  with  clinical  and  radiologic  signs  of
erforation  or  peritonitis  and  stage  IV  colonic  tumors  were
xcluded.  At  the  time  of  presentation,  patients  were  offered
urgery  or  SEMS  according  to  a  multidisciplinary  decision.
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Medical  records  from  these  patients  were  analyzed  to  col-
ect  demographic  data,  ASA  classiﬁcation,  tumor  location,
ancer  stage,  type  of  SEMS,  Karnofsky  index,  surgical  time,
ost-surgical  complications  (Clavien--Dindo  classiﬁcation),
ype  of  surgery,  total  hospital  stay  (including  all  hospital-
zations),  rate  of  primary  anastomosis,  stoma  rate  (including
emporary  and  deﬁnitive  stomas),  intra-operative  mortality,
ospital  mortality,  overall  survival  to  death  and  recurrence
ree  survival.  Overall  survival  to  death  was  deﬁned  as  the
ime  from  surgery  or  SEMS  placement  to  death  and  recur-
ence  free  survival  was  deﬁned  as  the  time  from  surgery  or
EMS  placement  to  cancer  recurrence.
We  also  evaluated  the  technical  and  clinical  success  of
EMS.  Technical  success  was  considered  when  the  colonic
tent  was  correctly  deployed  across  the  stricture  without
omplications;  and  clinical  success  was  deﬁned  as  relief  of
bstructive  symptoms  within  72  h  after  stent  placement.  All
EMS  were  placed  under  endoscopic  and  ﬂuoroscopic  guid-
nce,  by  gastroenterologists  with  experience  in  colonic  stent
lacement  (more  than  twenty).  Correct  positioning  of  the
tent  was  conﬁrmed  using  both  ﬂuoroscopy  and  endoscopy.
alloon  predilatation  was  not  preformed.  Patients  in  whom
t  was  not  possible  to  place  SEMS  were  included  in  the
urgery  group.
In patients  who  underwent  surgery  for  colonic  decom-
ression,  the  type  of  surgical  procedure  was  determined  by
he  surgeon  according  to  tumor  location,  disease  staging  and
he  general  condition  of  the  patient.  Urgent  surgery  was  also
ndicated  in  cases  of  technical  failure  of  stenting,  stent  per-
oration  or  clinical  failure.  Local  oncologic  recurrence  and
istant  metastasis  were  identiﬁed  by  computed  tomography
CT)  or  colonoscopy.
.2.  Statistical  analysis
he  statistical  analysis  was  performed  using  the  Statistical
ackage  for  Social  Sciences  (SPSS)  program  version  19  (SPSS,
hicago,  IL,  USA).  Quantitative  variables  were  described
sing  means  and  standard  deviation.  Categorical  variables
ere  described  in  absolute  numbers  and  percentages.  Chi-
quare  test  and  Student’s  t-test,  were  used  to  compare
on-continuous  and  continuous  data,  respectively.  Onco-
ogic  recurrence  during  follow-up  was  analyzed  with  the
aplan--Meier  estimation  method  and  compared  between
roups  using  the  log-rank  test.  Signiﬁcance  was  set  at  a  p
alue  ≤0.05.
. Results
orty-two  patients  were  included.  During  the  study  period,
7  patients  underwent  SEMS  placement  and  met  the
nclusion  criteria  (SEMS  group).  Emergency  surgery  was
erformed  on  15  patients  (surgery  group)  --  Fig.  1.  Stents
ere  unable  to  be  deployed  in  three  patients  because
t  was  not  possible  to  pass  the  guidewire;  these  patients
nderwent  primary  surgical  decompression  and  were
ncluded  in  surgery  group.  The  mean  age  was  68.1  years
±12.6)  and  most  patients  were  male  59.5%  (n  =  25).  There
ere  no  signiﬁcant  differences  between  the  two  groups  in
elation  to  age,  sex,  ASA  classiﬁcation,  Karnofsky  index,
Reevaluation  of  SEMS  as  a  Bridge  to  Surgery  for  Acute  Left-Sided  Malignant  Colonic  Obstruction  79
30 patients proposed to SEMS  12 patien ts proposed  to
emergency surgery
27 SEMS
3 SEMS  related
perforations
3 failed stenting  (guidewir e
could not pass)
SEMS group
n=27
Surgery grou p
n=15 
Eligible pa tien ts
n=42
24 success ful
SEMS
ial  ﬂ
i
s
a
o
s
b
a
(
c
m
3
o
P
2
g
d
r
s
p
s
p
p
6
w
w
T
iFigure  1  Tr
tumor  location,  histologic  features  of  the  tumor,  cancer
stage  and  type  of  surgery  (Table  1).
3.1.  SEMS  group
In  all  patients,  the  type  of  SEMS  used  was  non  covered
SEMS.  The  technical  success  was  88.9%  (n  =  24)  and  the
clinical  success  was  85.2%  (n  =  23).  There  were  three  perfo-
rations  related  to  stents,  two  of  them  detected  during  the
procedure.  The  other  patient  developed  peritonitis  three
days  after  the  procedure  from  delayed  colonic  perforation.
All  these  stent-related  perforations  required  surgery  with
stoma  (two  temporary  and  one  deﬁnitive).  One  patient  had
a  stent  successfully  placed  but  failure  to  decompress  the
colon  was  observed;  an  emergency  Hartmann  procedure  was
performed,  with  posterior  reconstruction  of  colonic  tran-
sit.  There  were  no  deaths  related  to  the  procedure.  All  23
patients  who  underwent  surgery  after  a  successful  SEMS  had
a  primary  anastomosis,  with  a  mean  time  between  SEMS  and
surgery  of  26.3  days  (±15.1).
In  patients  with  successful  SEMS  placement  followed  by
elective  surgery,  three  require  a  protective  stoma  (two  tem-
porary  and  one  deﬁnitive).
In  total,  the  stoma  rate  was  26%  (n  =  7):  four  temporary
and  three  deﬁnitive.  Deﬁnitive  stoma  resulted  from  anasto-
motic  leakage,  oncologic  recurrence  before  reconstruction
of  colonic  transit  and  multiple  post-surgical  complications
(respiratory  and  cardiac)  in  a  patient  with  several  comor-
bidities.3.2.  Surgery  group
Surgery  was  successful  in  relieving  obstruction  in  all  15
patients.  The  types  of  surgical  procedures  are  summarized
S
O
sow  diagram.
n  Table  1.  A  laparotomic  approach  was  used  in  all  patients
ubmitted  to  urgent  surgery.  Three  patients  had  a  primary
nastomosis,  one  with  a  protective  temporary  stoma.  All
ther  patients  required  surgery  with  the  construction  of  a
toma.  In  the  majority  of  patients  (n  =  8,  61.5%)  it  was  possi-
le  to  reconstruct  colonic  transit.  Cancer  recurrence  (n  =  2),
 death  not  related  to  cancer  (n  =  1),  abdominal  abscess
n  =  1)  and  anastomotic  dehiscence  (n  =  1)  in  patients  with
omorbidities  were  the  causes  of  deﬁnitive  stomas.  The
ean  hospital  stay  was  18.9  days  (±10.1).
.3.  SEMS  vs  surgery  group  --  short  and  long  term
utcomes
rimary  anastomosis  was  higher  in  SEMS  group  (85.1%  vs
0%,  p  =  0.001)  and  the  stoma  rate  was  superior  in  surgery
roup  (86.7%  vs  25.9%,  p  =  0.001).  However,  there  was  no
ifference  between  the  temporary  and  deﬁnitive  stoma
ate,  in  SEMS  and  surgery  group,  respectively  (temporary
toma:  57.1%  vs  61.5%;  deﬁnitive  stoma:  42.8%  vs  38%,
 =  0.84).
Although  postoperative  complications  were  higher  in  the
urgery  group  (Clavien--Dindo  score  ≥III:  36%  vs  58.3%,
 =  0.24)  and  the  total  hospital  stay  (26.3  vs  18.9  days,
 =  0.051)  and  success  of  primary  anastomosis  (86.7%  vs
6.7%,  p  =  0.22)  were  higher  in  SEMS  group,  the  differences
ere  not  statistically  signiﬁcant.  Comparison  of  patients
ith  SEMS  or  urgent  surgery  is  demonstrated  in  Table  2.
here  was  no  intra-operative  or  hospital  mortality  at  30  days
n  both  groups.The  median  time  of  follow-up  was  41.8  months  in  the
EMS  group  and  35.3  months  in  the  surgery  group  (p  =  0.82).
ne  and  ﬁve  year  overall  survival  was  identical  in  SEMS  and
urgery  groups  (100%/56%  vs  93%/43%,  p  =  0.14),  although
80  I.  Ribeiro  et  al.
Table  1  Patients  and  tumor  characteristics.
Patients  and  tumor  characteristics  SEMS  group  (n  =  27)  Surgery  group  (n  =  15)  p
Age  mean  (±SD)  68.2  (±11.9)  68.1  (±17.5)  0.98
Sex 62.9%  (17)  53.3%  (8)  0.54
Karnofsky index  mean  (±SD)  68.2  (±7.5)  68.1  (±9.9)  0.16
ASA classiﬁcation  0.73
I 14.8%  (4)  20%  (3)
II 59.3%  (16)  46.7%  (7)
III 25.9%  (7)  33.3%  (5)
IV 0%  (0)  0%  (0)
V 0%  (0)  0%  (0)
Tumor location  0.12
Rectosigmoid  colon  25.9%  (7)  6.7%  (1)
Sigmoid colon  40.7%  (11)  26.7%  (4)
Descendent  colon  29.6%  (8)  46.7%  (7)
Splenic ﬂexure  3.7%  (1)  20%  (3)
Cancer stage  0.078
I 7.4%  (2)  0%  (0)
II 81.5%  (22) 60%  (9)
III 11.1%  (3)  40%  (6)
Histology 0.12
Well differentiated  adenocarcinoma  14.8%  (4)  100%  (15)
Moderately  differentiated  adenocarcinoma  85%  (23)  0%  (0)
Type of  surgery  (I)  0.29
Laparotomy 85%  (23)  100%  (15)
Laparoscopy  14.8%  (4)  0%  (0)
Type of  surgery  (II)  0.47
High anterior  resection  of  rectum  29.4%  (5)  6.7%  (1)
Sigmoidectomy  44.4%  (12)  40%  (6)
 (10)  53.3%  (8)
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 trend  toward  a  higher  survival  in  the  SEMS  group  was
bserved.  The  survival  curves  are  illustrated  in  Fig.  2. Five
atients  (18.5%)  in  the  SEMS  group  and  six  patients  (40%)  in
he  surgery  group  died  during  follow-up.  Of  these  patients,
our  in  the  SEMS  group  (80%)  and  four  in  the  surgery  group
66.6%)  died  of  cancer.
The  three  and  ﬁve-year  recurrence  free  survival  was
ot  signiﬁcantly  different  between  the  SEMS  and  surgery
roups  (24%/50%  vs  20%/36%,  p  =  0.68),  however  with  a
rend  toward  a  higher  recurrence  in  the  SEMS  group
Fig.  3).
Thirteen  patients,  nine  (33.3%)  in  the  stent  group  and
our  (26.6%)  in  the  surgery  group  developed  cancer  recur-
ence,  all  with  distant  metastasis.  Among  patients  with
ecurrence,  ﬁve  patients  had  stage  IIIB/C  tumor  (38.5%)
nd  only  one  patient  had  a  stent  related  perforation.  In
atients  with  oncologic  recurrence,  the  time  between  SEMS
lacement  and  surgery  was  not  statistically  different  from
hose  with  no  oncologic  recurrence  (16.7  days  vs  13.2  days,
 =  0.06).  In  the  SEMS  group,  oncologic  recurrence  was  not
nﬂuenced  by  perforation  (11.1%  vs  11.1%,  p  =  1)  and  tumor
tage  (stage  III  11.1%  vs  11.1%,  p  =  1)  did  not  inﬂuence  onco-
ogic  recurrence.
Urgent surgery Urgent stenting
Figure  2  Time  to  mortality.
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Table  2  SEMS  and  surgery  groups  complications  and  mortality.
Characteristics  SEMS  group  (n  =  27)  Surgery  group  (n  =  15)  p
Follow-up  time  mean  (months)  41.8  35.3  0.82
Primary anastomosis  85.1%  (23)  20%  (3)  0.001
Stoma rate  25.9%  (7)  86.7%  (13)  0.001
Stoma type  0.84
Temporary 57.1%  (4)  61.5%  (8)
Deﬁnitive 42.8%  (3)  38.5%  (5)
Success of  primary  anastomosis  86.7%  (20)  66.7%  (2)  0.22
Clavien--Dindo  classiﬁcation  0.24
I--II 63%  (12)  41%  (5)
III--V 36%  (7)  58.2%  (7)
Total hospital  stay  (days)  mean  (±SD)  26.3  (±15.1)  18.9  (±10.1)  0.051
Intraoperative  mortality  0%  (0)  0%  (0)  NA
Overall survival  0.14
1 year  100%  (27)  93%  (14)
5 year  56%  (15)  43%  (6)
Recurrence  free-survival 0.68
3 year  24%  (6)  20%  (3)
5 year 50%  (14)  
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4. Discussion
Colonic  obstruction  represents  a  surgical  emergency  asso-
ciated  with  a  high  degree  of  morbidity  and  mortality
because  of  the  generally  poor  condition  of  these  patients.
Colonic  stenting  is  an  alternative  method  for  treatment
of  obstructive  left-sided  colon  cancer.  However,  its  use  as
a  preoperative  bridge  to  surgery  remains  controversial,
because  of  signiﬁcant  heterogeneity  between  studies  in
i
a
C36%  (5)
elation  to  tumor  location,  staging,  study  design,  follow-up
nd  overall  morbidity.
In  our  study,  the  overall  stoma  rate  was  lower  and  the  pri-
ary  anastomosis  rate  was  higher  in  the  SEMS  group,  results
lso  found  in  other  data.3,8,11 These  results  support  the
ypothesis  that  SEMS  placement  as  a bridge  to  surgery  allows
mprovement  of  the  patient’s  general  condition  creating  the
ight  conditions  for  a  successful  primary  anastomosis.  How-
ver,  there  was  no  signiﬁcant  difference  in  the  rates  of
ermanent  stoma,  a  conclusion  also  supported  by  a  meta-
nalysis  published  by  Tan  et  al.  These  authors  suggest  that
valuation  of  the  stoma  rate  is  essential  when  comparing  the
wo  different  interventions,  because  creation  of  a  deﬁnitive
toma  can  have  profound  effects  on  the  psychosocial  well-
eing  of  patients  and  specialized  counseling  is  needed  to
mprove  quality  of  life  signiﬁcantly.3 In  our  study,  one  perma-
ent  stoma  in  the  SEMS  group  was  performed  after  leakage  of
 primary  anastomosis;  probably,  in  this  case,  bowel  decom-
ression  and  improvement  of  the  patients’  clinical  condition
ere  insigniﬁcant  at  the  time  of  elective  surgery.  Intesti-
al  continuity  can  be  restored  in  only  60  percent  of  cases
ith  up  to  40  percent  morbidity.12 The  decision  to  create  a
toma  rather  than  to  restore  continuity  is  also  related  to  the
atient’s  overall  condition  and  stability.
Although  we  did  not  ﬁnd  any  statistically  signiﬁcant  dif-
erence  in  relation  to  the  total  hospital  stay,  there  was  a
rend  to  a  longer  hospital  stay  in  the  SEMS  group.  Eventually,
he  time  between  the  SEMS  placement  and  surgery  could
xplain  these  results.  SEMS  perforations,  which  required
mergency  operation  and  stoma  formation,  could  also  result
n  a  longer  hospital  stay.
In  contrast  to  some  RCT  studies,5,6 we  did  not  ﬁnd
ny  difference  in  post-operative  complications  using
lavien--Dindo  classiﬁcation.  The  therapy  used  to  correct
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 speciﬁc  complication  is  the  basis  of  this  classiﬁcation  in
rder  to  rank  a  complication  in  an  objective  and  repro-
ucible  manner.  A  systematic  review  and  meta-analysis
ublished  by  Guang-Yao  Ye  et  al.  also  did  not  ﬁnd  any
ifferences  between  the  two  groups  regarding  anastomotic
eakage  and  intra-abdominal  infection.13 This  may  be
elated  to  the  emergency  nature  of  the  surgery,  the  type  of
urgeon  or  the  time  after  colonic  stenting.8
A  series  of  studies  showed  that  SEMS  have  an  overall
ate  for  relief  of  obstruction  of  84--94%,  with  complications
uch  as  perforation  (4%),  stent  migration  (10--12%)  and
e-obstruction  (7--10%),  causing  a  cumulative  mortality  of
%.11,14 The  technical  and  clinical  success  of  SEMS  varies  in
ccordance  to  published  studies.  Sebastian  et  al.14 reported
 technical  success  rate  of  91.9%  and  a  clinical  success  rate
f  71.7%  for  SEMS  placement  as  a  bridge  to  elective  surgery.
irlet  et  al.7 had  a  53%  technical  failure  for  stent  inser-
ion,  two  cases  of  stent  perforation  in  the  SEMS  group  and
ne  perforation  in  a  non-randomized  patient  leading  to  clo-
ure  of  the  trial.  Van  Hooft  et  al.15 also  stopped  their  trial
ecause  they  found  an  unexpectedly  increased  absolute  risk
f  30-day  morbidity  in  the  SEMS  group,  with  almost  20%  of
tent  related  perforations.  A  meta-analysis  published  by  Tan
t  al.  concluded  that  technical  and  clinical  success  rates  for
tenting  were  lower  than  expected  (70%  and  69%,  respec-
ively),  with  almost  20%  of  SEMS  related  perforations.3 The
tent  related  technical  failure  could  be  related  to  the  level
f  experience  of  the  operator.  In  our  study,  we  found  11%
f  stent  related  perforations,  with  a  technical  and  clinical
uccess  of  88.9%  and  85.2%,  respectively.  All  stents  were
laced  by  gastroenterologists  with  experience  in  SEMS  place-
ent  for  the  treatment  of  colonic  obstruction.  Operator
xperience  and  technical  expertise  in  stent  placement  has
een  shown  to  reduce  signiﬁcantly  the  number  of  stent-
elated  complications.  Although  Van  Hooft  et  al.  reported
hat  stent  placement  was  performed  by  experienced  endo-
copists,  other  RCT  did  not  report  the  level  of  experience
f  stent  placement  required.  Small  et  al.  have  also  sug-
ested  that  the  degree  of  occlusion  is  another  risk  factor
or  SEMS  complications  as  the  completely  occluded  bowel
ay  result  in  friable  micro-perforated  tissue  and  present  as
 very  tight  stricture  that  makes  stent  deployment  techni-
ally  difﬁcult.16 In  our  study  it  was  not  possible  to  assess  the
ype  of  obstruction  but,  eventually,  the  type  of  obstruction
ould  inﬂuence  the  rate  of  perforations.
The  oncological  consequences  of  potential  tumor  dis-
emination  caused  by  perforations  are  unclear,  but  the
ossibility  of  dissemination  is  worrisome.  A  recent  retro-
pective  study  found  that  the  3-year  overall  survival  (85.2  vs
2.8%;  p  =  0.65)  and  recurrence  free  survival  (80.7  vs  78.6%;
 =  0.916)  were  not  signiﬁcantly  different  between  the  stent
nd  surgery  groups;  however,  in  the  stent  group,  perfora-
ion  was  identiﬁed  as  an  independent  risk  factor  for  cancer
ecurrence  (odds  ratio  22.0;  95%  CI,  1.3--362.9;  p  =  0.030)
nd  seeded  metastasis  (odds  ratio  46.0;  95%  CI,  2.0--1047.8;
 =  0.016).11 Another  retrospective  study  found  that  SEMS
ad  an  adverse  effect  on  5-year  overall  and  disease-free  sur-
ival  rates.17 The  poorer  outcomes  in  this  group  could  have
een  due  to  patients  with  more  advanced  disease  presenting
ith  emergency  bowel  obstruction.  On  the  other  hand,
ne  prospective  study  reported  longer  survival  in  patients
ho  underwent  SEMS  placement  (hazard  ratio  0.412;  95%I.  Ribeiro  et  al.
I,  0.217--0.789;  p  =  0.007).18 Considering  the  differences
n  published  studies  regarding  tumor  recurrence  and  sur-
ival,  there  are  no  proven  differences  in  long-term  outcomes
etween  the  two  treatment  approaches.  In  our  study,  we  did
ot  ﬁnd  any  statistically  signiﬁcant  difference  in  one  and  ﬁve
ears  overall  survival  and  in  three  and  ﬁve  years  recurrence
ree  survival.  Stent  related  perforation  and  tumor  stage  did
ot  inﬂuence  tumor  recurrence  in  the  SEMS  group.
This  study  is  limited  by  its  retrospective  design,  and
he  small  number  of  patients  from  a  single  institution.
mall  number  of  patients  should  be  considered  with  caution
hen  interpreting  these  results.  Patients  were  not  ran-
omly  assigned,  and  selection  bias  may  have  confounded  our
ata.  Some  data  could  be  missed,  including  post-operative
omplications  and  oncological  recurrence.  However,  we  ana-
yzed  a very  important  variable,  not  always  explored  in  these
ypes  of  studies:  the  oncologic  recurrence.  We  think  this  is  a
trong  point  of  our  study.  Also,  to  the  best  of  our  knowledge,
his  is  the  ﬁrst  Portuguese  study  comparing  SEMS  as  a  bridge
o  surgery  with  emergency  surgery  in  patients  with  obstruc-
ive  left-sided  colon  cancer.  It  shows  that  SEMS  has  some
dvantages  because  it  is  associated  with  a  lower  overall
toma  rate  and  a  higher  primary  anastomosis  rate.  However,
here  are  no  differences  in  complications,  overall  survival
nd  recurrence  free  survival.
More  studies  to  resolve  these  conﬂicting  results  regarding
reatment  of  left-sided  obstructive  cancer  are  needed.
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